Focus: Market Access Policy, Value & Access
Adam is Dolon’s Managing Partner and Head of the Market Access Policy service line. A health economist by training, he has over 18 years’ market access experience in consulting and the pharmaceutical industry, including roles at Aventis, GlaxoSmithKline and Baxter Healthcare. He is an expert in healthcare policy relating to pricing, reimbursement, and patient access to orphan medicines.
